Acellular pertussis vaccines and complement killing of Bordetella pertussis

Infection and Immunity

Volumn 72, Issue 12, 2004, Pages 7346-7351

  Weiss, Alison A ^a   Patton, Angela K ^a   Millen, Scott H ^a   Chang, Swei Ju ^b   Ward, Joel I ^b   Bernstein, David I ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; BACTERIUM LIPOPOLYSACCHARIDE; COMPLEMENT MEMBRANE ATTACK COMPLEX; CROSS REACTING ANTIGEN; FILAMENTOUS HEMAGGLUTININ; HEMAGGLUTININ; HEPATITIS A VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; OUTER MEMBRANE PROTEIN; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS TOXOID; PERTUSSIS VACCINE; TOXOID; UNCLASSIFIED DRUG;

ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BLOOD SAMPLING; BORDETELLA PERTUSSIS; CLINICAL TRIAL; COLONY FORMING UNIT; CONJUGATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HOST RESISTANCE; HUMAN; IMMUNIZATION; INFECTION PREVENTION; NONHUMAN; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTIBODIES, BACTERIAL; BLOOD BACTERICIDAL ACTIVITY; BORDETELLA PERTUSSIS; COMPLEMENT SYSTEM PROTEINS; DOUBLE-BLIND METHOD; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PERTUSSIS VACCINE; PROSPECTIVE STUDIES; VACCINES, ACELLULAR;

EID: 9244246834     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.12.7346-7351.2004     Document Type: Article

References (22)

1. Abramson, T., H. Kedem, and D. A. Relman. 2001. Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin. Infect. Immun. 69:2650-2658.
2. Barnes, M. G., and A. A. Weiss. 2003. Activation of the complement cascade by Bordetella pertussis. FEMS Microbiol. Lett. 220:271-275.
3. Barnes, M. G., and A. A. Weiss. 2001. BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition. Infect. Immun. 69:3067-3072.
4. Brandtzaeg, P. 1995. The role of humoral mucosal immunity in the induction and maintenance of chronic airway infections. Am. J. Respir. Crit. Care Med. 151:2081-2086.
5. Cherry, J. D., J. Gornbein, U. Heininger, and K. Stehr. 1998. A search for serologic correlates of immunity to Bordetella pertusis cough illnesses. Vaccine 16:1901-1906.
6. El-Madhun, A. S., R. J. Cox, and L. R. Haaheim. 1999. The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination. J. Infect. Dis. 180:1356-1360.
7. Fernandez, R. C., and A. A. Weiss. 1994. Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect. Immun. 62:4727-4738.
8. Fernandez, R. C., and A. A. Weiss. 1998. Serum resistance in bvg-regulated mutants of Bordetella pertussis. FEMS Microbiol. Lett. 163:57-63.
9. Gotto, J. W., T. Eckhardt, P. A. Reilly, J. V. Scott, J. L. Cowell, T. N. Metcalf III, K. Mountzouros, J. J. Gibbons, Jr., and M. Siegel. 1993. Biochemical and immunological properties of two forms of pertactin, the 69,000-molecular-weight outer membrane protein of Bordetella pertussis. Infect. Immun. 61:2211-2215.
10. Gray, L. S., K. S. Huber, M. C. Gray, E. L. Hewlett, and V. H. Engelhard. 1989. Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein. J. Immunol. 142:1631-1638.
11. Griffiss, J. M., and D. K. Goroff. 1983. IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms. J. Immunol. 130:2882-2885.
12. + T-cell ratio in lymph node cells upon in vitro mitogenic stimulation by highly purified, water-soluble S3-S4 dimer of pertussis toxin. Infect. Immun. 69:3073-3081.
13. Le, T., J. D. Cherry, S. J. Chang, M. D. Knoll, M. L. Lee, S. Barenkamp, D. Bernstein, R. Edelman, K. M. Edwards, D. Greenberg, W. Keitel, J. Treanor, and J. I. Ward. 2004. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT study. J. Infect. Dis. 190:535-544.
14. Lynn, F., G. F. Reed, and B. D. Meade. 1996. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens. Clin. Diagn. Lab. Immunol. 3:689-700.
15. McGuirk, P., and K. H. Mills. 2000. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of 1L-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur. J. Immunol. 30:415-422.
16. Millen, S. H., D. I. Bernstein, B. Connelly, J. I. Ward, S. J. Chang, and A. A. Weiss. 2004. Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells. Infect. Immun. 72:615-620.
17. Persson, C. G., I. Erjefalt, U. Alkner, C. Baumgarten, L. Greiff, B. Gustafsson, A. Luts, U. Pipkorn, F. Sundler, and C. Svensson. 1991. Plasma exudation as a first line respiratory mucosal defence. Clin. Exp. Allergy 21:17-24.
18. Storsaeter, J., H. O. Hallander, L. Gustafsson, and P. Olin. 1998. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916.
19. Weingart, C. L., W. A. Keitel, K. M. Edwards, and A. A. Weiss. 2000. Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults. Infect. Immun. 68:7175-7179.
20. Weiss, A. A., and S. Falkow. 1983. Transposon insertion and subsequent donor formation promoted by Tn501 in Bordetella pertussis. J. Bacteriol. 153:304-309.
21. Weiss, A. A., P. S. Mobberley, R. C. Fernandez, and C. M. Mink. 1999. Characterization of human bactericidal antibodies to Bordetella pertussis. Infect. Immun. 67:1424-1431.
22. Zanardi, L., F. B. Pascual, K. Bisgard, T. Murphy, M. Wharton, and E. Maurice. 2002. Pertussis - United States, 1997-2000. Morb. Mortal Wkly. Rep. 51:73-76.